Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Accumulated Expenses: 2015-2024

Historic Accumulated Expenses for HUTCHMED (China) (HCM) over the last 10 years, with Dec 2024 value amounting to $29.8 million.

  • HUTCHMED (China)'s Accumulated Expenses fell 22.36% to $20.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $20.4 million, marking a year-over-year decrease of 22.36%. This contributed to the annual value of $29.8 million for FY2024, which is 33.96% down from last year.
  • According to the latest figures from FY2024, HUTCHMED (China)'s Accumulated Expenses is $29.8 million, which was down 33.96% from $45.0 million recorded in FY2023.
  • In the past 5 years, HUTCHMED (China)'s Accumulated Expenses registered a high of $45.0 million during FY2023, and its lowest value of $22.0 million during FY2020.
  • For the 3-year period, HUTCHMED (China)'s Accumulated Expenses averaged around $39.1 million, with its median value being $42.4 million (2022).
  • Per our database at Business Quant, HUTCHMED (China)'s Accumulated Expenses spiked by 90.09% in 2021 and then slumped by 33.96% in 2024.
  • HUTCHMED (China)'s Accumulated Expenses (Yearly) stood at $22.0 million in 2020, then skyrocketed by 90.09% to $41.8 million in 2021, then rose by 1.57% to $42.4 million in 2022, then rose by 6.14% to $45.0 million in 2023, then crashed by 33.96% to $29.8 million in 2024.